Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 23,063 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q1
S-3 GROUP for ABBOTT LABORATORIES
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $60,000.00 income
Agriculture, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q1
BOEING COMPANY for BOEING COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate
Aviation/Airlines/Airports, Aerospace, Defense, Foreign Relations
View →
Q1
CURA STRATEGIES for GLOBAL LIFE TECHNOLOGIES
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $10,000.00 income
Health Issues, Defense, Budget/Appropriations
View →
Q1
ALSTON & BIRD LLP for HOSPITAL ASSOCIATION OF OREGON
1st Quarter (Jan 1 - Mar 31) 2025 · Oregon · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
CROSSROADS STRATEGIES, LLC for VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
ALSTON & BIRD LLP for HOLOGIC, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $160,000.00 income
Health Issues
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for FLAGSHIP PIONEERING
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $80,000.00 income
Health Issues, Budget/Appropriations
View →
Q1
CROSSROADS STRATEGIES, LLC for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q1
THE NICKLES GROUP, LLC for JOHNSON & JOHNSON SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Bankruptcy
View →
Q1
ULTRAGENYX PHARMACEUTICAL INC. for ULTRAGENYX PHARMACEUTICAL INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Budget/Appropriations, Medicare/Medicaid
View →
Q1
ALSTON & BIRD LLP for HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $30,000.00 income
Health Issues
View →
Q1
MILLER STRATEGIES, LLC for TIDES MEDICAL
1st Quarter (Jan 1 - Mar 31) 2025 · Louisiana · $120,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
SOLVENTUM CORPORATION for SOLVENTUM CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Utah · House · Senate
Health Issues, Medicare/Medicaid, Defense, Trade (domestic/foreign)
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for CRINETICS PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
S-3 GROUP for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $30,000.00 income
Health Issues
View →
Q1
THE NICKLES GROUP, LLC for AMERICAN DENTAL ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid, Banking
View →
Q1
KING & SPALDING LLP for SOLACE HEALTH
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House
Health Issues
View →
Q1
S-3 GROUP for DAVITA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Colorado · House · Senate · $50,000.00 income
Health Issues
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for ASTELLAS PHARMA US, INC
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $80,000.00 income
Health Issues
View →
Q1
CURA STRATEGIES for PKD FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2025 · Missouri · House · Senate · $30,000.00 income
Budget/Appropriations, Health Issues, Defense
View →
Q1
BELL & LINDSAY, INC. for OYE THEREPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Indiana · House · Senate · $30,000.00 income
Health Issues
View →
Q1
S-3 GROUP for VAPOR TECHNOLOGY ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Science/Technology
View →
Q1
S-3 GROUP for FRESENIUS KABI
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Health Issues, Copyright/Patent/Trademark
View →
Q1
ABBOTT LABORATORIES for ABBOTT LABORATORIES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Agriculture
View →
Q1
ALSTON & BIRD LLP for HCA HEALTHCARE
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid
View →
Previous Page 805 of 923 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem